Rituximab en el síndrome antifosfolípido: ¿siempre, nunca o a veces?

Ugarte, Amaia; Ruiz Irastorza, Guillermo

Rituximab en el síndrome antifosfolípido: ¿siempre, nunca o a veces? / Rituximab in antiphospholipid syndrome: Always, never, sometimes?

Ugarte, Amaia; Ruiz Irastorza, Guillermo.

Affiliation

Ugarte, Amaia; Hospital Universitario Cruces. España
Ruiz Irastorza, Guillermo; Hospital Universitario Cruces. España

Med. clín (Ed. impr.) ; 144(3): 115-117, feb. 2015.

Article in Es | IBECS | ID: ibc-131581

Responsible library: ES1.1

Localization: BNCS

RESUMEN

RESUMEN

No disponible

Subject(s)

Humans; Antiphospholipid Syndrome/epidemiology; Antiphospholipid Syndrome/prevention & control; Thrombosis/epidemiology; Thrombosis/prevention & control; Risk Factors; Antibodies, Monoclonal/therapeutic use; Anticoagulants/therapeutic use; Vitamin K/antagonists & inhibitors; Heparin, Low-Molecular-Weight/therapeutic use; Immunologic Factors/therapeutic use; Glucocorticoids/therapeutic use; Immunosuppressive Agents/therapeutic use

Search on Google

Add to My VHL

XML

Collection: 06-national / ES Database: IBECS Main subject: Thrombosis / Risk Factors / Antiphospholipid Syndrome / Antibodies, Monoclonal Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: Es Journal: Med. clín (Ed. impr.) Year: 2015 Document type: Article

Search on Google

Add to My VHL

XML